Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conformational dynamics of cohesin/Scc2 loading complex are regulated by Smc3 acetylation and ATP binding. | Nat Commun | 2023 | 37739959 | PubTator, text mining | PubMed |
| Epigenetics, cryptorchidism, and infertility. | Basic Clin Androl | 2023 | 37730534 | PubTator, text mining | PubMed |
| Context-dependent perturbations in chromatin folding and the transcriptome by cohesin and related factors. | Nat Commun | 2023 | 37726281 | PubTator, text mining | PubMed |
| Endogenous expression of inactive lysine deacetylases reveals deacetylation-dependent cellular mechanisms. | PLoS One | 2023 | 37721967 | PubTator, text mining | PubMed |
| Identifying genetic regulatory variants that affect transcription factor activity. | Cell Genom | 2023 | 37719147 | PubTator, text mining | PubMed |
| Medicinal chemistry advances in targeting class I histone deacetylases. | Explor Target Antitumor Ther | 2023 | 37711592 | PubTator, text mining | PubMed |
| Activity Guided Azide-methyllysine Photo-trapping for Substrate Profiling of Lysine Demethylases. | J Am Chem Soc | 2023 | 37703462 | PubTator, text mining | PubMed |
| The complex biology of aryl hydrocarbon receptor activation in cancer and beyond. | Biochem Pharmacol | 2023 | 37696456 | PubTator, text mining | PubMed |
| Preparative Biocatalytic Synthesis of α-Ketomethylselenobutyrate-A Putative Agent for Cancer Therapy. | Molecules | 2023 | 37687007 | PubTator, text mining | PubMed |
| Mocetinostat activates Krüppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis. | JCI Insight | 2023 | 37681413 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy. | Eur J Med Chem | 2023 | 37659198 | PubTator, text mining | PubMed |
| PROTAC chemical probes for histone deacetylase enzymes. | RSC Chem Biol | 2023 | 37654508 | PubTator, text mining | PubMed |
| A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis. | Medicine (Baltimore) | 2023 | 37653756 | PubTator, text mining | PubMed |
| Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer. | Theranostics | 2023 | 37649598 | PubTator, text mining | PubMed |
| Epilepsy phenotype and gene ontology analysis of the 129 genes in a large neurodevelopmental disorders cohort. | Front Neurol | 2023 | 37645600 | PubTator, text mining | PubMed |
| Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. | Signal Transduct Target Ther | 2023 | 37644009 | PubTator, text mining | PubMed |
| Synthesis of N-aminophalimides derived from α-amino acids: Theoretical study to find them as HDAC8 inhibitors by docking simulations and in vitro assays. | Chem Biol Drug Des | 2023 | 37641461 | PubTator, text mining | PubMed |
| Histone deacetylase 6's function in viral infection, innate immunity, and disease: latest advances. | Front Immunol | 2023 | 37638049 | PubTator, text mining | PubMed |
| Histone Modification of Colorectal Cancer by Natural Products. | Pharmaceuticals (Basel) | 2023 | 37631010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=15